Zobrazeno 1 - 10
of 16
pro vyhledávání: '"CP McEntee"'
Autor:
CP McEntee, S Houston, CM Finlay, S Rossi, G Liu, TN Shaw, J Casulli, M Fife, C Smedley, TS Griffith, M Pepper, T Hussell, PM Hansbro, J-M Schwartz, H Paidassi, MA Travis
A rapid immune response to pathogen re-exposure underpins immunological memory, with protection against divergent pathogens such as heterologous or novel viral strains requiring crossreactive memory T cells. Understanding the pathways that control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44050d8f155ebe6f1a20303ba77dc549
https://doi.org/10.1101/2023.03.02.527395
https://doi.org/10.1101/2023.03.02.527395
Autor:
Natalia Muñoz-Wolf, Jean-Claude Sirard, Analía Rial, Julien Tabareau, José A. Chabalgoity, Delphine Fougeron
Publikováno v:
Future Microbiology
Future Microbiology, 2016, 11 (9), pp.1167-77. ⟨10.2217/fmb-2016-0045⟩
Future Microbiology, Future Medicine, 2016, 11 (9), pp.1167-77. ⟨10.2217/fmb-2016-0045⟩
Future Microbiology, 2016, 11 (9), pp.1167-77. ⟨10.2217/fmb-2016-0045⟩
Future Microbiology, Future Medicine, 2016, 11 (9), pp.1167-77. ⟨10.2217/fmb-2016-0045⟩
Aim: To evaluate efficacy of sublingual flagellin to treat acute pneumonia. Materials & methods: Mice were treated sublingually with flagellin and challenged intranasally with a lethal dose of pneumococcus. Flagellins lacking TLR5 or NLRC4 activation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1408326e3fe624dc3e91dd3b574423e
https://doi.org/10.2217/fmb-2016-0045
https://doi.org/10.2217/fmb-2016-0045
Autor:
Lavelle EC; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. Electronic address: lavellee@tcd.ie., McEntee CP; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Publikováno v:
Immunity [Immunity] 2024 Apr 09; Vol. 57 (4), pp. 772-789.
Autor:
Dow J; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom., Cytlak UM; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom.; Targeted Therapy Group, Division of Cancer Sciences, Manchester, United Kingdom., Casulli J; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom., McEntee CP; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom., Smedley C; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom., Hodge SH; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom., D'Elia RV; Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom; and.; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom., Hepworth MR; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom., Travis MA; Lydia Becker Institute for Immunology and Inflammation, Manchester, United Kingdom.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom.; Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2023 Mar 01; Vol. 210 (5), pp. 618-627.
Autor:
Muñoz-Wolf N; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland; Translational & Respiratory Immunology Lab, Department of Clinical Medicine, School of Medicine, Trinity Biomedical Sciences Institute, Dublin D02 R590, Ireland; Clinical Medicine Tallaght University Hospital, Dublin D24 NR04, Ireland., Ward RW; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Hearnden CH; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Sharp FA; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Geoghegan J; Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., O'Grady K; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., McEntee CP; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Shanahan KA; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Guy C; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Bowie AG; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Campbell M; Smurfit Institute of Genetics, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland., Roces CB; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Anderluzzi G; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Webb C; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Perrie Y; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Creagh E; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Lavelle EC; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland; Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN) & Advanced Materials Bio-Engineering Research Centre (AMBER), Trinity College Dublin, Dublin D02 PN40, Ireland. Electronic address: lavellee@tcd.ie.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2023 Jan 17; Vol. 4 (1), pp. 100899.
Autor:
Turley JL; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland., Moran HBT; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland., McEntee CP; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland., O'Grady K; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland., Muñoz-Wolf N; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland., Jin L; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL, 32610, USA., Follmann F; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark., Andersen P; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark., Andersson M; Division Bioscience and Materials, RISE (Research Institutes of Sweden), Forskargatan 18, 151 36, Södertälje, Sweden., Lavelle EC; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland; Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN) & Advanced Materials Bio-Engineering Research Centre (AMBER), Trinity College Dublin, Dublin 2, D02 PN40, Ireland. Electronic address: lavellee@tcd.ie.
Publikováno v:
Biomaterials [Biomaterials] 2021 Aug; Vol. 275, pp. 120961. Date of Electronic Publication: 2021 Jun 16.
Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines.
Autor:
Albutti A; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland.; Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia., Longet S; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland., McEntee CP; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland., Quinn S; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland., Liddicoat A; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland., Rîmniceanu C; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden., Lycke N; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden., Lynch L; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland., Cardell S; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden., Lavelle EC; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland.; Centre for Research on Adaptative Nanostructures and Nanodevices & Advanced Materials Bio-Engineering Research Centre, Trinity College Dublin, D02 PN40 Dublin, Ireland.
Publikováno v:
Vaccines [Vaccines (Basel)] 2021 Jun 08; Vol. 9 (6). Date of Electronic Publication: 2021 Jun 08.
Autor:
McEntee CP; Lydia Becker Institute for Immunology and Inflammation, Manchester, UK.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, UK.; Faculty of Biology, Medicine and Health, Manchester Collaborative Centre for Inflammation Research (MCCIR), Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK., Gunaltay S; Lydia Becker Institute for Immunology and Inflammation, Manchester, UK.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, UK.; Faculty of Biology, Medicine and Health, Manchester Collaborative Centre for Inflammation Research (MCCIR), Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK., Travis MA; Lydia Becker Institute for Immunology and Inflammation, Manchester, UK.; Wellcome Trust Centre for Cell-Matrix Research, Manchester, UK.; Faculty of Biology, Medicine and Health, Manchester Collaborative Centre for Inflammation Research (MCCIR), Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Publikováno v:
Immunology [Immunology] 2020 Jun; Vol. 160 (2), pp. 139-148. Date of Electronic Publication: 2019 Dec 25.
Autor:
McEntee CP; Adjuvant Research Group, School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland., Moran HBT; Adjuvant Research Group, School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland., Muñoz-Wolf N; Adjuvant Research Group, School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland., Liddicoat AM; Adjuvant Research Group, School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland., Carroll EC; Adjuvant Research Group, School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland., Erbo-Wern J; Department of Infectious Disease Immunology, Adjuvant Research, Staten Serum Institute, Copenhagen, Denmark., Coulter IS; Sigmoid Pharma, The Invent Centre, Dublin City University, Dublin, Ireland., Andersen P; Department of Infectious Disease Immunology, Adjuvant Research, Staten Serum Institute, Copenhagen, Denmark., Follmann F; Department of Infectious Disease Immunology, Adjuvant Research, Staten Serum Institute, Copenhagen, Denmark., Lavelle EC; Adjuvant Research Group, School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland; Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN), Advanced Materials and BioEngineering Research Centre (AMBER), Trinity College Dublin, Ireland. Electronic address: lavellee@tcd.ie.
Publikováno v:
Vaccine [Vaccine] 2020 Jan 16; Vol. 38 (3), pp. 635-643. Date of Electronic Publication: 2019 Nov 11.
Autor:
Longet S; 1Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02 R590 Ireland., Abautret-Daly A; 1Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02 R590 Ireland., Davitt CJH; 1Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02 R590 Ireland., McEntee CP; 1Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02 R590 Ireland., Aversa V; 2Sublimity Therapeutics Limited, Dublin City University, Alpha Innovation Campus, Old Finglas Road, Dublin, D11 KXN4 Ireland., Rosa M; 2Sublimity Therapeutics Limited, Dublin City University, Alpha Innovation Campus, Old Finglas Road, Dublin, D11 KXN4 Ireland., Coulter IS; 2Sublimity Therapeutics Limited, Dublin City University, Alpha Innovation Campus, Old Finglas Road, Dublin, D11 KXN4 Ireland., Holmgren J; 3University of Gothenburg Vaccine Research Institute, Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden., Raghavan S; 3University of Gothenburg Vaccine Research Institute, Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden., Lavelle EC; 1Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02 R590 Ireland.; 4Centre for Research on Adaptive Nanostructures and Nanodevices & Advanced Materials Bio-Engineering Research Centre, Trinity College Dublin, Dublin 2, D02 PN40 Ireland.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2019 Oct 25; Vol. 4, pp. 45. Date of Electronic Publication: 2019 Oct 25 (Print Publication: 2019).